State Street Corp Eyenovia, Inc. Transaction History

State Street Corp

$2.47 Trillion
Q4 2024

A detailed history of State Street Corp transactions in Eyenovia, Inc. stock. As of the latest transaction made, State Street Corp holds 133,917 shares of EYEN stock, worth $233,015. This represents 0.0% of its overall portfolio holdings.

Number of Shares

133,917

Previous 133,917 -0.0%

Holding current value

$233,015

Previous $69,000 71.01%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.46 - $1.44 $18,630 - $58,320	40,500 Added 43.35%	133,917 $69,000
Q2 2024 Aug 14, 2024	SELL	$0.52 - $1.06 $221,449 - $451,416	-425,865 Reduced 82.01%	93,417 $55,000
Q1 2024 May 15, 2024	BUY	$0.99 - $2.37 $30,789 - $73,707	31,100 Added 6.37%	519,282 $514,000
Q4 2023 Feb 14, 2024	SELL	$1.08 - $2.08 $69,876 - $134,576	-64,700 Reduced 11.7%	488,182 $1.02 Million
Q3 2023 Nov 14, 2023	BUY	$1.57 - $2.54 $173,485 - $280,670	110,500 Added 24.98%	552,882 $917,000
Q2 2023 Aug 14, 2023	BUY	$2.21 - $5.75 $794,417 - $2.07 Million	359,465 Added 433.52%	442,382 $1.05 Million
Q1 2023 May 15, 2023	BUY	$1.72 - $3.53 $16,168 - $33,182	9,400 Added 12.79%	82,917 $292,000
Q4 2022 Feb 14, 2023	BUY	$1.54 - $2.74 $18,326 - $32,606	11,900 Added 19.31%	73,517 $119,000
Q1 2022 May 16, 2022	BUY	$2.66 - $3.99 $13,877 - $20,815	5,217 Added 9.25%	61,617 $188,000
Q4 2021 Feb 14, 2022	BUY	$3.5 - $6.58 $131,950 - $248,066	37,700 Added 201.6%	56,400 $226,000
Q3 2021 Nov 15, 2021	BUY	$3.97 - $5.64 $74,239 - $105,468	18,700 New	18,700 $92,000

Others Institutions Holding EYEN

# of Institutions

Shares Held

5.68M

Call Options Held

72.9K

Put Options Held

36.3K

View Full List

About EYENOVIA, INC.

Ticker EYEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,212,900
Market Cap $59.5M
Description
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the develop...

More about EYEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Eyenovia, Inc. Transaction History